Skip to main content
Clinical Trials/NL-OMON51315
NL-OMON51315
Withdrawn
N/A

Assessing Overall Survival, Quality of Life, Frailty, Comorbidity Indexes, Healthcare Usage, and Pharmacoeconomics in Elderly Patients with Acute Myeloid Leukemia - ZEALOUS-AM

Medisch Centrum Leeuwarden0 sites100 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
AML
Sponsor
Medisch Centrum Leeuwarden
Enrollment
100
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Medisch Centrum Leeuwarden

Eligibility Criteria

Inclusion Criteria

  • Patients in the Dutch province of Friesland may present at any of the 4 Frisian
  • Hospitals. Complicated cases such as elderly patients with AML are referred to
  • the MCL. Patients from outside of the province of Friesland are uncommon.

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Age upon diagnosis \<\= 65 years
  • Patients diagnosed with APL (t(15;17\), WHO 2016\)

Outcomes

Primary Outcomes

Not specified

Similar Trials